All stock lists
Enliven Therapeutics, Inc. (NASDAQ:ELVN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
41.16
Insider Score
––Not scored
ELVN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ELVN Stock Insider Trading Activity
ELVN stock’s insider trading shows 19 sales on the open market for an estimated $11.80M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Garland J. Scott Director | Option exercise | 13,000 | $15.47 | $201.11K | New | 13,000 | Oct 1, 2026 | — | Form 4 |
| Garland J. Scott Director | Sell | 13,000 | $46.67 | $606.72K | 100% | 0 | Oct 1, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Option exercise | 3,982 | $14.85 | $59.13K | 9.9% | 44,018 | Sep 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 3,535 | $50.03 | $176.85K | 8.0% | 40,483 | Sep 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 2,194 | $50.72 | $111.27K | 5.4% | 38,289 | Sep 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 289 | $51.49 | $14.88K | 0.8% | 38,000 | Sep 17, 2026 | — | Form 4 |
| Collins Helen Louise Other | Option exercise | 5,000 | $2.48 | $12.40K | 20.0% | 30,000 | Sep 17, 2026 | — | Form 4 |
| Collins Helen Louise Other | Sell | 2,916 | $50.03 | $145.89K | 9.7% | 27,084 | Sep 17, 2026 | — | Form 4 |
| Collins Helen Louise Other | Sell | 1,844 | $50.71 | $93.51K | 6.8% | 25,240 | Sep 17, 2026 | — | Form 4 |
| Collins Helen Louise Other | Sell | 240 | $51.48 | $12.36K | 1.0% | 25,000 | Sep 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 1,388 | $59.35 | $82.38K | 3.4% | 40,036 | Aug 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 4,630 | $58.35 | $270.17K | 10.1% | 41,424 | Aug 17, 2026 | — | Form 4 |
| Collins Helen Louise Other | Sell | 3,900 | $58.37 | $227.65K | 13.0% | 26,100 | Aug 17, 2026 | — | Form 4 |
| Collins Helen Louise Other | Option exercise | 5,000 | $2.48 | $12.40K | 20.0% | 30,000 | Aug 17, 2026 | — | Form 4 |
| Collins Helen Louise Other | Sell | 1,100 | $59.35 | $65.28K | 4.2% | 25,000 | Aug 17, 2026 | — | Form 4 |
| Derynck Mika K Director | Option exercise | 87,373 | $2.48 | $216.69K | New | 87,373 | Aug 4, 2026 | — | Form 4 |
| Derynck Mika K Director | Option exercise | 27,567 | $25.28 | $696.89K | 31.6% | 114,940 | Aug 4, 2026 | — | Form 4 |
| Derynck Mika K Director | Option exercise | 23,364 | $14.85 | $346.96K | 20.3% | 138,304 | Aug 4, 2026 | — | Form 4 |
| Derynck Mika K Director | Option exercise | 20,491 | $22.47 | $460.43K | 14.8% | 158,795 | Aug 4, 2026 | — | Form 4 |
| Derynck Mika K Director | Sell | 158,795 | $60.21 | $9.56M | 100% | 0 | Aug 4, 2026 | — | Form 4 |
| Collins Helen Louise Other | Sell | 2,063 | $52.39 | $108.08K | 7.0% | 27,247 | Jul 17, 2026 | — | Form 4 |
| Collins Helen Louise Other | Sell | 63 | $53.92 | $3.40K | 0.3% | 25,000 | Jul 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Option exercise | 1,072 | $2.48 | $2.66K | 2.1% | 52,072 | Jul 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 324 | $49.97 | $16.19K | 0.6% | 51,748 | Jul 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 369 | $51.48 | $19.00K | 0.7% | 51,379 | Jul 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 2,564 | $52.32 | $134.14K | 5.0% | 48,815 | Jul 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 2,638 | $53.38 | $140.82K | 5.4% | 46,177 | Jul 17, 2026 | — | Form 4 |
| Hohl Benjamin CFO | Sell | 123 | $53.87 | $6.63K | 0.3% | 46,054 | Jul 17, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.